{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:45:41Z","timestamp":1780339541005,"version":"3.54.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jgyn.2016.09.012","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T04:01:31Z","timestamp":1477108891000},"page":"1280-1298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Int\u00e9r\u00eat des progestatifs dans la pr\u00e9vention de la pr\u00e9maturit\u00e9 spontan\u00e9e"],"prefix":"10.1016","volume":"45","author":[{"given":"E.","family":"Azria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2016.09.012_bib0450","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/aogs.12791","article-title":"Clinical roles and applications of progesterone in reproductive medicine: an overview","volume":"94","author":"Filicori","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0455","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1053\/j.semperi.2014.08.013","article-title":"Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations","volume":"38","author":"Feghali","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0460","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJMcibr1100071","article-title":"How does progesterone relax the uterus in pregnancy?","volume":"364","author":"Zakar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0465","doi-asserted-by":"crossref","first-page":"223e1","DOI":"10.1016\/j.ajog.2013.01.020","article-title":"Prevention of preterm birth by progestational agents: what are the molecular mechanisms?","volume":"208","author":"Nold","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0470","series-title":"The use of progesterone to prevent preterm delivery","author":"The Royal College of Obstetricians and Gynaecologists","year":"2010"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0475","series-title":"The use of progesterone for the prevention of preterm delivery","author":"SOGC","year":"2013"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0480","series-title":"M\u00e9droxyprogest\u00e9rone","author":"Le CRAT","year":"2016"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0485","doi-asserted-by":"crossref","first-page":"398e1","DOI":"10.1016\/j.ajog.2012.08.015","article-title":"Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation","volume":"207","author":"Caritis","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0490","doi-asserted-by":"crossref","first-page":"169e1","DOI":"10.1016\/j.ajog.2007.11.065","article-title":"Transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate","volume":"199","author":"Hemauer","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0495","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1749-6632.1967.tb14686.x","article-title":"Induced genital anomalies","volume":"142","author":"Goldman","year":"1967","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0500","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1749-6632.1958.tb46779.x","article-title":"Some biological activities of certain progestogens. I. 17\u00a0Alpha-hydroxyprogesterone 17-n-caproate","volume":"71","author":"Kessler","year":"1958","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0505","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/tera.1420280208","article-title":"Evaluation of the teratogenic potential of delalutin (17\u00a0alpha-hydroxyprogesterone caproate) in mice","volume":"28","author":"Seegmiller","year":"1983","journal-title":"Teratology"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0510","first-page":"359","article-title":"Assay of progestins for fetal virilizing properties using the mouse","volume":"23","author":"Johnstone","year":"1964","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0515","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/0002-9378(93)90296-U","article-title":"Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17\u03b1-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1\/6J mouse","volume":"169","author":"Carbone","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0520","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archpedi.159.10.957","article-title":"Maternal progestin intake and risk of hypospadias","volume":"159","author":"Carmichael","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0525","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1741-4520.2006.00128.x","article-title":"Population-based case-control teratogenic study of hydroxyprogesterone treatment during pregnancy","volume":"46","author":"Dud\u00e1s","year":"2006","journal-title":"Congenit Anom (Kyoto)"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0530","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)48490-6","article-title":"Congenital malformations among offspring exposed in utero to progestins, Olmsted Country, Minnesota, 1936\u20131974","volume":"43","author":"Resseguie","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0535","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1471-0528.2012.03448.x","article-title":"Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial","volume":"120","author":"Serra","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0540","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.AOG.0000281348.51499.bc","article-title":"Follow-up of children exposed in utero to 17 \u03b1-hydroxyprogesterone caproate compared with placebo","volume":"110","author":"Northen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0545","doi-asserted-by":"crossref","first-page":"e0122341","DOI":"10.1371\/journal.pone.0122341","article-title":"STOPPIT baby follow-up study: the effect of prophylactic progesterone in twin pregnancy on childhood outcome","volume":"10","author":"McNamara","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0550","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/uog.9093","article-title":"Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone","volume":"38","author":"Rode","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0555","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17\u00a0alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0560","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(09)60947-8","article-title":"Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis","volume":"373","author":"Norman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0565","article-title":"Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial","author":"Norman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0570","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3109\/01443615.2013.820266","article-title":"Progesterone use after successful treatment of threatened pre-term delivery","volume":"33","author":"Areia","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0575","first-page":"207","article-title":"17\u00a0alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30mm","author":"Grobman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0580","doi-asserted-by":"crossref","first-page":"206e1","DOI":"10.1016\/j.ajog.2011.12.026","article-title":"Prevention of preterm delivery after successful tocolysis in preterm labor by 17\u00a0alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"206","author":"Rozenberg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0585","first-page":"45","article-title":"Maintenance therapy by vaginal progesterone after threatened idiopathic preterm labor: a randomized placebo-controlled double-blind trial","volume":"4","author":"Shahami","year":"2010","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0590","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clnu.2009.03.007","article-title":"l-Arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double-bind controlled trial","volume":"28","author":"Winer","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0595","first-page":"206","article-title":"Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data","author":"Romero","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0600","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jhep.2005.09.017","article-title":"Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy","volume":"44","author":"Vallejo","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0605","first-page":"165","article-title":"[Effects of micronized natural progesterone on the liver during the third trimester of pregnancy]","volume":"25","author":"Benifla","year":"1997","journal-title":"Contracept Fertil Sex"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0610","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.510260216","article-title":"Intrahepatic cholestasis of pregnancy: a French prospective study","author":"Bacq","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0615","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/AOG.0b013e31822ad6aa","article-title":"17\u03b1-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial","volume":"118","author":"Lim","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0620","doi-asserted-by":"crossref","first-page":"82e1","DOI":"10.1016\/j.ajog.2015.02.021","article-title":"Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study","volume":"213","author":"Brizot","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0625","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/dc07-0564","article-title":"Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery","volume":"30","author":"Rebarber","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0630","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/AOG.0b013e3181a9454b","article-title":"Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy","volume":"114","author":"Waters","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0635","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1055\/s-0031-1280854","article-title":"The rates of abnormal glucose challenge tests and gestational diabetes in women receiving 17\u03b1-hydroxyprogesterone caproate","volume":"28","author":"Wolfe","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0640","doi-asserted-by":"crossref","first-page":"248e1","DOI":"10.1016\/j.ajog.2010.06.016","article-title":"Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial","volume":"203","author":"Combs","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0645","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A trial of 17\u00a0alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0650","doi-asserted-by":"crossref","first-page":"392e1","DOI":"10.1016\/j.ajog.2009.06.036","article-title":"The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies","volume":"201","author":"Gyamfi","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0655","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9378(83)91051-7","article-title":"The effect of 17\u00a0alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population","volume":"146","author":"Hauth","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0660","doi-asserted-by":"crossref","first-page":"190e1","DOI":"10.1016\/j.ajog.2012.12.021","article-title":"Can transabdominal ultrasound be used as a screening test for short cervical length?","volume":"208","author":"Friedman","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0665","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0670","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0675","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/uog.15953","article-title":"Vaginal progesterone decreases preterm birth\u226434weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study","volume":"48","author":"Romero","year":"2016","journal-title":"Ultrasound Obs Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0680","first-page":"65","article-title":"Double blind study of an agent to prevent preterm delivery among women at increased risk","volume":"Serie IV","author":"Papiernik","year":"1970","journal-title":"Ed Scher"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0685","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM197510022931401","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor","volume":"293","author":"Johnson","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0690","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajog.2010.03.020","article-title":"Was the preterm birth rate in the placebo group too high in the Meis MFMU Network trial of 17-OHPC?","volume":"202","author":"Iams","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0695","first-page":"CD003099","article-title":"Castor oil, bath and\/or enema for cervical priming and induction of labour","volume":"7","author":"Kelly","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0700","doi-asserted-by":"crossref","first-page":"453e1","DOI":"10.1016\/j.ajog.2010.03.023","article-title":"17\u00a0alpha-hydroxyprogesterone caproate vehicle, castor oil, enhances the contractile effect of oxytocin in human myometrium in pregnancy","volume":"202","author":"O'Sullivan","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0705","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ajog.2005.05.077","article-title":"Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery","volume":"193","author":"Spong","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0710","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mefs.2010.03.007","article-title":"Progesterone supplementation for prevention of preterm labor: a randomized controlled trial","volume":"15","author":"Ibrahim","year":"2010","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0715","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1447-0756.2011.01524.x","article-title":"Efficacy of 17\u03b1-hydroxyprogesterone caproate in prevention of preterm delivery","volume":"37","author":"Saghafi","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0720","first-page":"CD004947","article-title":"Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth","volume":"7","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0725","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0730","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O\u2019Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0735","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00404-009-1351-2","article-title":"Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial","volume":"283","author":"Cetingoz","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0740","first-page":"11","article-title":"Evaluation of the effect of progesterone on prevention of preterm delivery and its complications","volume":"14","author":"Akbari","year":"2009","journal-title":"Sci J Kurdistan"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0745","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/01443610902980878","article-title":"Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India","volume":"29","author":"Majhi","year":"2009","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0750","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijgo.2008.08.029","article-title":"Oral micronized progesterone for prevention of preterm birth","volume":"104","author":"Rai","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0755","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0031-1274509","article-title":"A randomized trial of micronized progesterone for the prevention of recurrent preterm birth","volume":"28","author":"Glover","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0760","doi-asserted-by":"crossref","first-page":"485e1","DOI":"10.1016\/j.ajog.2014.10.1097","article-title":"17\u00a0alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial","volume":"212","author":"Winer","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0765","doi-asserted-by":"crossref","first-page":"375e1","DOI":"10.1016\/j.ajog.2009.08.015","article-title":"Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length","volume":"201","author":"Owen","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0770","doi-asserted-by":"crossref","first-page":"351e1","DOI":"10.1016\/j.ajog.2010.02.019","article-title":"et al., 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length","volume":"202","author":"Berghella","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0775","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/uog.5159","article-title":"Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"DeFranco","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0780","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/AOG.0b013e31820ca847","article-title":"Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis","volume":"117","author":"Berghella","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0785","doi-asserted-by":"crossref","first-page":"42e1","DOI":"10.1016\/j.ajog.2012.10.877","article-title":"Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison meta-analysis","volume":"208","author":"Conde-Agudelo","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0790","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/uog.12300","article-title":"Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix","volume":"41","author":"Alfirevic","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0795","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(12)60030-0","article-title":"Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial","volume":"379","author":"Goya","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0800","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000328719","article-title":"Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor","volume":"72","author":"Arikan","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0805","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0028-2243(91)90118-5","article-title":"The use of micronized progesterone in the treatment of menace of preterm delivery","volume":"40","author":"Noblot","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0810","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1447-0756.2010.01434.x","article-title":"Comparison of success rate of nifedipine, progesterone, and bed rest for inhibiting uterine contraction in threatened preterm labor","volume":"37","author":"Chawanpaiboon","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0815","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9378(86)90595-8","article-title":"The effects of oral administration of progesterone for premature labor","volume":"154","author":"Erny","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0820","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00404-011-2026-3","article-title":"Single dose 17\u00a0alpha-hydroxyprogesterone caproate in preterm labor: a randomized trial","volume":"285","author":"Tan","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0825","first-page":"CD006770","article-title":"Progestational agents for treating threatened or established preterm labour","volume":"1","author":"Su","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0830","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-9378(99)70582-X","article-title":"Efficacy of maintenance therapy after acute tocolysis: a meta-analysis","volume":"181","author":"Sanchez-Ramos","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.03.031","article-title":"Vaginal progesterone for maintenance tocolysis: a systematic review and meta-analysis of randomized trials","author":"Suhag","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0840","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/1471-0528.13061","article-title":"Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial","volume":"122","author":"Martinez de Tejada","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0845","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.13956","article-title":"Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial","author":"Palacio","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0850","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3109\/14767058.2014.892922","article-title":"The use of 17-hydroxy progesterone in women with arrested preterm labor: a randomized clinical trial","volume":"27","author":"Briery","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0855","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0b013e318193c677","article-title":"Prevention of preterm birth in triplets using 17\u00a0alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"113","author":"Caritis","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0860","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1471-0528.13031","article-title":"A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity","volume":"122","author":"Awwad","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0865","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1471-0528.13032","article-title":"Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis","volume":"122","author":"Schuit","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0870","doi-asserted-by":"crossref","first-page":"194e1","DOI":"10.1016\/j.ajog.2013.01.032","article-title":"Prevention of preterm delivery by 17\u00a0alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial","volume":"208","author":"Senat","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0875","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3109\/14767051003702786","article-title":"Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-\u03b1 hydroxyprogesterone caproate","volume":"23","author":"Durnwald","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0880","doi-asserted-by":"crossref","first-page":"221e1","DOI":"10.1016\/j.ajog.2010.12.042","article-title":"17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial","volume":"204","author":"Combs","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0885","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/uog.9092","article-title":"Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis","volume":"38","author":"Klein","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2016.09.012_bib0445","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00404-015-3767-1","article-title":"Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety","volume":"293","author":"El-refaie","year":"2016","journal-title":"Arch Gynecol Obstet"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231516301132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231516301132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T09:28:14Z","timestamp":1536312494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231516301132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":89,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0368231516301132"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2016.09.012","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Int\u00e9r\u00eat des progestatifs dans la pr\u00e9vention de la pr\u00e9maturit\u00e9 spontan\u00e9e","name":"articletitle","label":"Article Title"},{"value":"Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgyn.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}